United Kingdom · Report · Written statement
UIN HLWS518
Statutory scheme to control the cost of branded health service medicines
Introduced
12 March 2018
Last action
12 March 2018 · Written statement
Status
Lords
Sponsors
—
Subjects
Discovery layer
Source updated
12 March 2018
Summary
This statement is to update the House that Regulations were laid before Parliament on 9 March 2018 to revise the statutory scheme to control the cost of branded health service medicines. The changes will come into force on 1 April 2018, and are estimated ...
This text is taken from the official record. PoliticalRepo does not editorialize.
Timeline
12 March 2018
Written statement
This statement is to update the House that Regulations were laid before Parliament on 9 March 2018 to revise the statutory scheme to control the cost of branded health service medicines. The changes will come into force on 1 April 2018, and are estimated ...
Source: Lords
Votes
No vote records are attached yet.
Versions
No version snapshots stored. Document URLs remain at the source.
Documents
No documents linked.
Leesvertaling
Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.
Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.
Sponsors
- · Department of Health and Social Care · Answering body
Related records
No cross-record relationships stored yet.
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.
- Official source: https://questions-statements.parliament.uk/written-statements/detail/2018-03-12/HLWS518
- Open data entity: https://questions-statements-api.parliament.uk/api/writtenstatements/statements/859922
- uk · ws-859922 · source updated 12 March 2018